A detailed history of Miracle Mile Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Miracle Mile Advisors, LLC holds 39,986 shares of AZN stock, worth $2.73 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
39,986
Previous 7,327 445.73%
Holding current value
$2.73 Million
Previous $570,000 359.47%
% of portfolio
0.06%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

BUY
$63.2 - $79.58 $2.06 Million - $2.6 Million
32,659 Added 445.73%
39,986 $2.62 Million
Q3 2024

Oct 07, 2024

SELL
$76.67 - $87.62 $76,516 - $87,444
-998 Reduced 11.99%
7,327 $570,000
Q2 2024

Jul 18, 2024

BUY
$66.81 - $80.83 $47,501 - $57,470
711 Added 9.34%
8,325 $649,000
Q1 2024

Apr 18, 2024

BUY
$61.03 - $69.57 $34,909 - $39,794
572 Added 8.12%
7,614 $515,000
Q4 2023

Jan 22, 2024

SELL
$61.89 - $69.28 $2.04 Million - $2.28 Million
-32,978 Reduced 82.4%
7,042 $474,000
Q3 2023

Oct 25, 2023

SELL
$64.85 - $71.7 $32,424 - $35,850
-500 Reduced 1.23%
40,020 $2.71 Million
Q2 2023

Jul 13, 2023

BUY
$69.91 - $75.81 $41,946 - $45,486
600 Added 1.5%
40,520 $2.9 Million
Q4 2022

Jan 20, 2023

BUY
$54.21 - $70.44 $74,430 - $96,714
1,373 Added 3.56%
39,920 $0
Q3 2022

Oct 24, 2022

SELL
$53.02 - $135.75 $16,860 - $43,168
-318 Reduced 0.82%
38,547 $2.11 Million
Q2 2022

Jul 15, 2022

SELL
$59.26 - $71.14 $829 - $995
-14 Reduced 0.04%
38,865 $2.57 Million
Q1 2022

Apr 25, 2022

BUY
$55.72 - $67.12 $1.95 Million - $2.35 Million
35,003 Added 903.07%
38,879 $2.58 Million
Q4 2021

Jan 18, 2022

BUY
$54.02 - $63.83 $209,381 - $247,405
3,876 New
3,876 $226,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $211B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Miracle Mile Advisors, LLC Portfolio

Follow Miracle Mile Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miracle Mile Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miracle Mile Advisors, LLC with notifications on news.